摘要
Abstract
Objective To observe the clinical effect of acupoint injection of Salvia miltiorrhiza on stable chronic obstructive pulmonary disease (COPD). Methods Sixty-eight patients with stable COPD were divided into treatment group (n = 34) and control group (n = 34) in a single-blind randomised controlled trial. The treatment group received injection of Salvia miltiorrhiza at the acupoints of Dingchuan, Feishu, Shenshu, Pishu, and Zusanli on the basis of routine comprehensive treatment once per week for three months. The control group received routine comprehensive treatment for three months. Before and after treatment, both groups underwent COPD assessment test (CAT) , and the forced expiratory volume in one second (FEV1), FEV1%, FEV1/forced vital capacity (FVC) , CD4 + and CD8 + percentages, and CD4 + / CD8+ were measured or calculated. Results Compared with the control group, the treatment group showed significantly lower CAT scores (P<0. 01) , significantly higher CD4+ percentage and CD4+/CD8 + (P<0. 05 , or P<0. 01) , significantly lower CD8+ percentage (P<0. 01) , and significantly higher FEV1 , FEV1 % , and FEV1/FVC (P<0. 01). Conclusion Acupoint injection of Salvia miltiorrhiza on the basis of routine comprehensive treatment can improve the quality of life, pulmonary ventilation function, and immunity of the patients with stable COPD.关键词
慢性阻塞性肺疾病/穴位注射/丹参注射液Key words
chronic obstructive pulmonary disease/ acupoint injection/ Salvia miltiorrhiza分类
医药卫生
